Walgreens Boots Alliance

Walgreens Boots Alliance, Inc. (Nasdaq: WBA) has announced the departure of James Kehoe, who served as the executive vice president and global chief financial officer. Kehoe will be leaving the company in mid-August to pursue an opportunity in the technology sector. In the interim, Manmohan Mahajan, the senior vice president and global controller, has been appointed as the interim global chief financial officer. The company will be conducting a search to fill the CFO role with a leader who possesses both strong financial expertise and healthcare experience.

Rosalind Brewer, the chief executive officer, expressed her appreciation for James Kehoe’s contributions to the company over the past five years and recognized his role in building a robust finance organization. She wished him well in his future endeavors. Meanwhile, she expressed confidence in Manmohan Mahajan, citing his reputation as a respected senior leader within the company.

Mahajan, who joined Walgreens Boots Alliance in 2016, has held various senior finance roles within the organization, showcasing his experience and familiarity with the company’s operations. With his appointment as interim global CFO, Todd Heckman has been named interim global controller. Walgreens Boots Alliance continues its focus on executing its healthcare transformation and growth strategy.

Walgreens Boots Alliance is a well-established healthcare, pharmacy, and retail leader with a presence in multiple countries, providing essential services to millions of customers and patients. The company aims to shape the future of healthcare by reimagining local healthcare and well-being for all through its diverse portfolio of brands and investments.

As the CFO transition takes place, the company remains committed to delivering value to its stakeholders, customers, and communities while furthering its purpose of creating more joyful lives through better health. The search for a new global chief financial officer will undoubtedly be closely watched by the industry as the company continues to navigate the evolving healthcare landscape.